Table 2

FVIII and VWF production by macrovascular ECs

Cell typePassage no.FVIII:C, mU/mLVWF:Ag, mU/mL
HPAEC* 3°°° 1.2 ± 0.2 (n = 10) 94.5 ± 0.1 (n = 10) 
HUVEC* 2°° <0.2 (n = 5) 214.9 ± 0.2 (n = 5) 
HUVEC 3°°° <0.2 (n = 5) 263.5 ± 8.5 (n = 5) 
HUAEC* 3°°° <0.2 (n = 5) 66.5 ± 0.1 (n = 5) 
HAEC* 2°° <0.2 (n = 5) 82.6 ± 0.1 (n = 5) 
Cell typePassage no.FVIII:C, mU/mLVWF:Ag, mU/mL
HPAEC* 3°°° 1.2 ± 0.2 (n = 10) 94.5 ± 0.1 (n = 10) 
HUVEC* 2°° <0.2 (n = 5) 214.9 ± 0.2 (n = 5) 
HUVEC 3°°° <0.2 (n = 5) 263.5 ± 8.5 (n = 5) 
HUAEC* 3°°° <0.2 (n = 5) 66.5 ± 0.1 (n = 5) 
HAEC* 2°° <0.2 (n = 5) 82.6 ± 0.1 (n = 5) 

Macrovascular cells provided frozen by the suppliers (*ScienCell; †Lonza) were thawed and plated in 96-well plates. Cells were at passages 2(°°) or 3(°°°) when supplied after 1 or 2 passages in vitro, respectively. After 1 week, culture medium was completely replaced by fresh medium, and, after a further 48-hour incubation period, FVIII:C was measured with Coatest SP FVIII assay and VWF:Ag with an ELISA. Results are expressed as the mean plus or minus SD of 5 or 10 microculture wells.

or Create an Account

Close Modal
Close Modal